GB virus C: The good boy virus?

Trends in Microbiology

Volumn 20, Issue 3, 2012, Pages 124-130

  Bhattarai, Nirjal ^a   Stapleton, Jack T ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Activation; GBV C; HIV; IL 2; T cell

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; STROMAL CELL DERIVED FACTOR 1;

APOPTOSIS; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL PROTECTION; DOWN REGULATION; GENOME ANALYSIS; HEPATITIS G; HEPATITIS G VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; INNATE IMMUNITY; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEROPREVALENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH1 CELL; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HIV INFECTIONS; HIV-1; HUMANS; T-LYMPHOCYTES; VIRUS REPLICATION;

GB VIRUS C; HEPATITIS C VIRUS;

EID: 84858000676     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.01.004     Document Type: Review

References (77)

1. Simons J.N., et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat. Med. 1995, 1:564-569.
2. Leary T.P., et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J. Med. Virol. 1996, 48:60-67.
3. Saito S., et al. Plus- and minus-stranded hepatitis G virus RNA in liver tissue and in peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 1997, 237:288-291.
4. Linnen J., et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996, 271:505-508.
5. Stapleton J.T. GB virus type C/Hepatitis G virus. Semin. Liver Dis. 2003, 23:137-148.
6. Mohr E.L., Stapleton J.T. GB virus type C interactions with HIV: the role of envelope glycoproteins. J. Viral Hepat. 2009, 16:757-768.
7. George S.L., et al. GB virus C replicates in primary T and B lymphocytes. J. Infect. Dis. 2006, 193:451-454.
8. Stapleton J.T., et al. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J. Gen. Virol. 2011, 92:233-246.
9. Tacke M., et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997, 26:1626-1633.
10. Thomas D.L., et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J. Infect. Dis. 1998, 177:539-542.
11. Williams C.F., et al. Persistent GB virus C infection and survival in HIV-infected men. N. Engl. J. Med. 2004, 350:981-990.
12. Dawson G.J., et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J. Med. Virol. 1996, 50:97-103.
13. Belyaev A.S., et al. Hepatitis G virus encodes protease activities which can effect processing of the virus putative nonstructural proteins. J. Virol. 1998, 72:868-872.
14. Stapleton J.T., Chaloner K. GB virus C infection and non-Hodgkin lymphoma: important to know but the jury is out. Int. J. Cancer 2010, 126:2759-2761.
15. Heringlake S., et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients?. J. Infect. Dis. 1998, 177:1723-1726.
16. Toyoda H., et al. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998, 17:209-213.
17. Lefrere J.J., et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J. Infect. Dis. 1999, 179:783-789.
18. Yeo A.E., et al. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann. Intern. Med. 2000, 132:959-963.
19. Xiang J., et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N. Engl. J. Med. 2001, 345:707-714.
20. Tillmann H.L., et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N. Engl. J. Med. 2001, 345:715-724.
21. Nunnari G., et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann. Intern. Med. 2003, 139:26-30.
22. Van der Bij A.K., et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J. Infect. Dis. 2005, 191:678-685.
23. Zhang W., et al. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med. 2006, 7:173-180.
24. Souza I.E., et al. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians. HIV Med. 2006, 7:25-31.
25. Rodriguez B., et al. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. J. Infect. Dis. 2003, 187:504-507.
26. Supapol W.B., et al. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J. Infect. Dis. 2008, 197:1369-1377.
27. Handelsman E., et al. Impact of GB virus type C infection on mother-to-child HIV transmission in the Women and Infants Transmission Study Cohort. HIV Med. 2007, 8:561-567.
28. Moore J.P., et al. The CCR5 and CXCR4 coreceptors: central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20:111-126.
29. Lederman M.M., et al. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006, 296:815-826.
30. Schwarze-Zander C., et al. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir. Ther. 2010, 15:745-752.
31. Nattermann J., et al. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003, 17:1457-1462.
32. Xiang J., et al. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004, 363:2040-2046.
33. Koedel Y., et al. Peptides derived from a distinct region of GB Virus C glycoprotein E2 mediate strain specific HIV-1 entry inhibition. J. Virol. 2011, 85:7037-7047.
34. Jung S., et al. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. AIDS 2007, 21:645-647.
35. + T-lymphocyte cell line. J. Gen. Virol. 2007, 88:3341-3346.
36. + Jurkat T cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:15570-15575.
37. Sanchez-Martin M.J., et al. Analysis of HIV-1 fusion peptide inhibition by synthetic peptides from E1 protein of GB virus C. J. Colloid Interface Sci. 2011, 360:124-131.
38. + cells. J. Immunol. 2009, 183:7860-7869.
39. Mohr E.L., et al. GB virus type C envelope protein E2 elicits antibodies that react with a cellular antigen on HIV-1 particles and neutralize diverse HIV-1 isolates. J. Immunol. 2010, 185:4496-4505.
40. Haynes B.F., Alam S.M. HIV-1 hides an Achilles' heel in virion lipids. Immunity 2008, 28:10-12.
41. Levy J.A. The importance of the innate immune system in controlling HIV infection and disease. Trends Immunol. 2001, 22:312-316.
42. Soumelis V., et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98:906-912.
43. Meyers J.H., et al. Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells. PLoS ONE 2007, 2:e458.
44. Donaghy H., et al. Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001, 98:2574-2576.
45. Feldman S., et al. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol. 2001, 101:201-210.
46. Kamga I., et al. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J. Infect. Dis. 2005, 192:303-310.
47. Lalle E., et al. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int. J. Immunopathol. Pharmacol. 2008, 21:161-171.
48. Capobianchi M.R., et al. Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients. Cell. Mol. Biol. 2006, 52:3-8.
49. Barcellini W., et al. TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994, 8:757-762.
50. Clerici M., et al. Human immunodeficiency virus (HIV) phenotype and interleukin-2/interleukin-10 ratio are associated markers of protection and progression in HIV infection. Blood 1996, 88:574-579.
51. Johann-Liang R., et al. Endogenous interleukin-2 serum levels in children infected with human immunodeficiency virus. Clin. Infect. Dis. 1997, 25:1233-1236.
52. Spellberg B., Edwards J.E. Type 1/Type 2 immunity in infectious diseases. Clin. Infect. Dis. 2001, 32:76-102.
53. Rydze, R.T. et al. (2012) GB virus C infection polarizes T cell cytokine gene expression towards a Th1 cytokine profile via NS5A protein expression. J. Infect. Dis. (in press).
54. Dianzani U., et al. Role of FAS in HIV infection. Curr. HIV Res. 2003, 1:405-417.
55. Moenkemeyer M., et al. GBV-C coinfection is negatively correlated to Fas expression and Fas-mediated apoptosis in HIV-1 infected patients. J. Med. Virol. 2008, 80:1933-1940.
56. Embretson J., et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993, 362:359-362.
57. Finkel T.H., et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1995, 1:129-134.
58. + T lymphocyte cell death in human immunodeficiency virus infection and AIDS. J. Gen. Virol. 2003, 84:1649-1661.
59. Badley A.D., et al. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ. 1999, 6:420-432.
60. + T cell count, and HIV plasma viral copy number. AIDS Res. Hum. Retroviruses 1999, 15:1509-1518.
61. Grossman Z., et al. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 2006, 12:289-295.
62. + T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 2003, 187:1534-1543.
63. Moir S., Fauci A.S. B cells in HIV infection and disease. Nat. Rev. Immunol. 2009, 9:235-245.
64. Maidana-Giret M.T., et al. GB virus type C infection modulates T-cell activation independently of HIV-1 viral load. AIDS 2009, 23:2277-2287.
65. George S.L., et al. Clinical isolates of GB virus type C vary in their ability to persist and replicate in peripheral blood mononuclear cell cultures. Virology 2003, 316:191-201.
66. Xiang J., et al. Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J. Virol. 2000, 74:9125-9133.
67. Ganusov V.V., De Boer R.J. Do most lymphocytes in humans really reside in the gut?. Trends Immunol. 2007, 28:514-518.
68. Nel A.E. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J. Allergy Clin. Immunol. 2002, 109:758-770.
69. Paredes R., et al. The potential role of interleukin-2 in patients with HIV infection. AIDS Rev. 2002, 4:36-40.
70. Stapleton J.T., et al. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy. AIDS 2009, 23:605-610.
71. Berzsenyi M.D., et al. Down-regulation of intra-hepatic T-cell signaling associated with GB virus C in a HCV/HIV co-infected group with reduced liver disease. J. Hepatol. 2011, 55:536-544.
72. Antony G.K., Dudek A.Z. Interleukin 2 in cancer therapy. Curr. Med. Chem. 2010, 17:3297-3302.
73. Pett S.L., et al. Role of interleukin-2 in patients with HIV infection. Drugs 2010, 70:1115-1130.
74. Abrams D., et al. Interleukin-2 therapy in patients with HIV infection. N. Engl. J. Med. 2009, 361:1548-1559.
75. Yee L.J. Host genetic determinants in hepatitis C virus infection. Genes Immun. 2004, 5:237-245.
76. Theodore D., Lemon S.M. GB virus C, hepatitis G virus, or human orphan flavivirus?. Hepatology 1997, 25:1285-1286.
77. Alter H.J. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997, 37:569-572.